Rotavirus epidemiology 5–6 years after universal rotavirus vaccination: persistent rotavirus activity in older children and elderly

References

• Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11–22.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23–33.
   PubMed Web of Science ®Google Scholar
• Hemming-Harlo M, Markkula J, Huhti L, et al. Decrease of rotavirus gastroenteritis to a low level without resurgence for 5 years after universal rotaTeq(R) vaccination in Finland. Pediatr Infect Dis J. 2016;35:1304–1308.
   PubMed Web of Science ®Google Scholar
• Braeckman T, Van Herck K, Meyer N, et al. Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study. Bmj. 2012;345:e4752.
   PubMed Web of Science ®Google Scholar
• Payne DC, Boom JA, Staat MA, et al. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis. 2013;57:13–20.
   PubMed Web of Science ®Google Scholar
• Bowen MD, Mijatovic-Rustempasic S, Esona MD, et al. Rotavirus strain trends during the postlicensure vaccine era: United States, 2008-2013. J Infect Dis. 2016;214:732–738.
   PubMed Web of Science ®Google Scholar
• Prelog M, Gorth P, Zwazl I, et al. Universal mass vaccination against rotavirus: Indirect effects on rotavirus infections in neonates and unvaccinated young infants not eligible for vaccination. J Infect Dis. 2016;214:546–555.
   PubMed Web of Science ®Google Scholar
• Anderson EJ, Shippee DB, Weinrobe MH, et al. Indirect protection of adults from rotavirus by pediatric rotavirus vaccination. Clin Infect Dis. 2013;56:755–760.
   PubMed Web of Science ®Google Scholar
• Karafillakis E, Hassounah S, Atchison C. Effectiveness and impact of rotavirus vaccines in Europe, 2006–2014. Vaccine. 2015;33:2097–2107.
   PubMed Web of Science ®Google Scholar
• Payne DC, Staat MA, Edwards KM, et al. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009. Clin Infect Dis. 2011;53:245–253.
   PubMed Web of Science ®Google Scholar
• Hemming M, Rasanen S, Huhti L, et al. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland. Eur J Pediatr. 2013;172:739–746.
   PubMed Web of Science ®Google Scholar
• Standaert B, Strens D, Alwan A, et al. Medium- to long-term impact of rotavirus vaccination on hospital care in Belgium: a 7-year follow-up of the rotavirus Belgium impact study (RotaBIS). Infect Dis Ther. 2016;5:31–44.
   PubMed Web of Science ®Google Scholar
• Anderson EJ, Katz BZ, Polin JA, et al. Rotavirus in adults requiring hospitalization. J Infect. 2012;64:89–95.
   PubMed Web of Science ®Google Scholar
• Gurgel RQ, Cuevas LE, Vieira SC, et al. Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg Infect Dis. 2007;13:1571–1573.
   PubMed Web of Science ®Google Scholar
• Correia JB, Patel MM, Nakagomi O, et al. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis. 2010;201:363–369.
   PubMed Web of Science ®Google Scholar
• Payne DC, Selvarangan R, Azimi PH, et al. Long-term consistency in rotavirus vaccine protection: RV5 and RV1 vaccine effectiveness in US children, 2012-2013. Clin Infect Dis. 2015;61:1792–1799.
   PubMed Web of Science ®Google Scholar
• Rasanen S, Lappalainen S, Halkosalo A, et al. Rotavirus gastroenteritis in Finnish children in 2006-2008, at the introduction of rotavirus vaccination. Scand J Infect Dis. 2011;43:58–63.
   PubMed Web of Science ®Google Scholar
• Matthijnssens J, Ciarlet M, Heiman E, et al. Full genome-based classification of rotaviruses reveals a common origin between human Wa-like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. J Virol. 2008;82:3204–3219.
   PubMed Web of Science ®Google Scholar
• Hemming-Harlo M, Vesikari T, Uhari M, et al. Sustained high effectiveness of RV5 on hospitalizations due to rotavirus gastroenteritis during 4 years in Finland. J Pediatric Infect Dis Soc. 2016; [Epub ahead of print]. doi:10.1093/jpids/piw061.
   PubMedGoogle Scholar
• Nakajima H, Nakagomi T, Kamisawa T, et al. Winter seasonality and rotavirus diarrhoea in adults. Lancet. 2001;357:1950.
   PubMed Web of Science ®Google Scholar
• Lopman BA, Curns AT, Yen C, et al. Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis. 2011;204:980–986.
   PubMed Web of Science ®Google Scholar
• Ianiro G, Delogu R, Bonomo P, RotaNet-Italy Study Group, et al. Molecular analysis of group A rotaviruses detected in adults and adolescents with severe acute gastroenteritis in Italy in 2012. J Med Virol. 2014;86:1073–1082.
   PubMed Web of Science ®Google Scholar
• Mijatovic-Rustempasic S, Roy S, Sturgeon M, et al. Full-genome sequence of the first G8P[14] rotavirus strain detected in the United States. Genome Announc. 2015;3:e000677–15. doi: 10.1128/genomeA.00677-15.
   Google Scholar
• Heylen E, Zeller M, Ciarlet M, et al. Comparative analysis of pentavalent rotavirus vaccine strains and G8 rotaviruses identified during vaccine trial in Africa. Sci Rep. 2015;5:14658.
   PubMed Web of Science ®Google Scholar
• Koopmans M, van de Poel W, Widdowson MA. Outbreak of infection with unusual rotavirus (G9P6) in the neonatal ward of a Dutch hospital. Euro Surveill. 2000;4:pii =1678. [cited 2016 Oct 19]. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=1678.
   Google Scholar
• Ramachandran M, Das BK, Vij A, et al. Unusual diversity of human rotavirus G and P genotypes in India. J Clin Microbiol. 1996;34:436–439.
   PubMed Web of Science ®Google Scholar
• Gentsch JR, Hull JJ, Teel EN, et al. G and P types of circulating rotavirus strains in the United States during 1996-2005: nine years of prevaccine data. J Infect Dis. 2009;200:S99–S105.
   Web of Science ®Google Scholar
• Zeller M, Rahman M, Heylen E, et al. Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. Vaccine. 2010;28:7507–7513.
   PubMed Web of Science ®Google Scholar
• Kirkwood CD, Boniface K, Barnes GL, et al. Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix(R) and RotaTeq(R), into the National Immunization Program of Australia. Pediatr Infect Dis J. 2011;30:S48–S53.
   PubMed Web of Science ®Google Scholar
• Hemming M, Vesikari T. Vaccine-derived human-bovine double reassortant rotavirus in infants with acute gastroenteritis. Pediatr Infect Dis J. 2012;31:992–994.
   PubMed Web of Science ®Google Scholar
• Velazquez FR, Matson DO, Guerrero ML, et al. Serum antibody as a marker of protection against natural rotavirus infection and disease. J Infect Dis. 2000;182:1602–1609.
   PubMed Web of Science ®Google Scholar
• Vesikari T. Rotavirus vaccination: a concise review. Clin Microbiol Infect. 2012;18:57–63.
   PubMed Web of Science ®Google Scholar
• Markkula J, Hemming M, Vesikari T. Detection of vaccine-derived rotavirus strains in nonimmunocompromised children up to 3-6 months after RotaTeq(R) vaccination. Pediatr Infect Dis J. 2015;34:296–298.
   PubMed Web of Science ®Google Scholar
• Ye S, Lambert SB, Grimwood K, et al. Comparison of test specificities of commercial antigen-based assays and in-house PCR methods for detection of rotavirus in stool specimens. J Clin Microbiol. 2015;53:295–297.
   PubMed Web of Science ®Google Scholar
• Lawrence J, He S, Martin J, et al. Safety and immunogenicity of pentavalent rotavirus vaccine in a randomized, double-blind, placebo-controlled study in healthy elderly subjects. Hum Vaccin Immunother. 2014;10:2247–2254.
   PubMed Web of Science ®Google Scholar
• Blazevic V, Lappalainen S, Nurminen K, et al. Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis. Vaccine. 2011;29:8126–8133.
   PubMed Web of Science ®Google Scholar